Julia Ernst, MS

A light-emitting diode (LED) device that uses 40 high-intensity blue LEDs, which can be configured to an individual patient's needs, and is free of ultraviolet (UV) light, may offer a new treatment option for patients with psoriasis.

The compound AIN457 (secukinumab) has been granted a unanimous vote of support for approval from the Dermatologic and Ophthalmic Drugs Advisory Committee to the Food and Drug Administration.

Amgen has released positive top-line results from the first of two Phase III studies of ABP 501, its candidate for the treatment of moderate-to-severe plaque psoriasis that is being developed as a biosimilar to adalimumab.

News from the literature on a possible link between atherosclerosis and psoriasis and quality of life for patients with this skin condition.

A new drug with the potential to join the existing class of monoclonal antibodies (mAbs) for plaque psoriasis has shown promising results in a Phase II study.

Ponesimod, a selective S1P1 receptor agonist, has been shown to be efficacious for improving both disease and quality of life markers in patients with moderate to severe chronic plaque psoriasis.

Ixekizumab, a drug being evaluated for the treatment of moderate-to-severe chronic plaque psoriasis, continues to demonstrate efficacy and safety in Phase III trials.

The National Psoriasis Foundation (NPF) recently announced a number of new programs and a five-year strategic mission for the organization with initiatives that are designed to increase research and uncover new treatments for all forms of psoriasis and psoriatic disease.

Two drugs currently on the market may also be beneficial as positron emission tomography radiotracers, which could possibly lead to imaging studies for the early detection of Alzheimer�s disease.

A new study by researchers in Canada shows that a majority of high school freshmen have at least one major risk factor for heart disease and stroke. These factors include obesity and elevated cholesterol levels, two problems that are also common in America. Results of the study may serve as a guide for US physicians to monitor and work to change heart disease and stroke risk in teenagers.

Macrophages taken from vitamin-D-deficient diabetics were more likely to become foam cells, one of the earliest markers of atherosclerosis.

Stem cell transplants may be a new, revolutionary way to treat Crohn's disease.

A new study has found that the cognitive abilities of individuals with type II diabetes decreases as blood sugar levels rise.

Researchers have discovered that a person’s risk of developing dementia and other types of cognitive disabilities may increase with exposure to second-hand smoke.

One out of every seven patients admitted to the hospital experiences adverse drug reactions during treatment.

Researchers at the University of Wisconsin-Madison have created heart muscle cells from "induced" stem cells.

Researchers have found that teenagers who watch the most television are more likely to exhibit symptoms of depression as young adults.

A researcher has developed a new set of tools that may enhance the ability of pediatric heart surgeons to perform cardiac surgery on young patients.

Researchers have discovered that electronic medical records can be used as a test for the efficacy of treatments for disease.

A new study has determined that women taking hormone replacement therapy for five years or more after menopause double their risk for breast cancer.

A new study found that a woman’s resting heart rate can be used as a factor in predicting coronary events.

A new study has found that giving infliximab to patients after intestinal resective surgery is an effective way to prevent endoscopic and histological recurrence of Crohn’s disease.

The inheritable aspect of schizophrenia may be due to, in large part, structural changes in DNA called copy number variants, not more common genetic variants that have been the focus in previous studies.

A research team has discovered a protein critical for the growth of pancreatic cancer tumors that, when expression was blocked, prevented tumor growth in mice.

A recent study found that only one-quarter of hospital patients are able to correctly identify their doctors and what roles the doctors had in their treatment.

A new study has found that diabetics are at a significantly higher risk of developing both Alzheimer's disease and other forms of dementia.

Researchers have discovered that ion channel disorders may account for one-third of unexplainable sudden cardiac death in young people.

A new study has found that high doses of inhaled corticosteroids are effective in limiting the severity and length of asthma attacks set off by colds.

A new study has shown positive results that PRIMA-1 could potentially become a new chemotherapy treatment for progestin-accelerated human breast cancer.

Medicare has widened the scope of its coverage of drugs used as off-label treatments in cancer patients.